• About Us
    • What We Do
    • Our Story
    • Board Members
    • Management Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • News
    • Corporate Announcements
    • Media
  • Contact
  • About Us
    • What We Do
    • Our Story
    • Board Members
    • Management Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • News
    • Corporate Announcements
    • Media
  • Contact
Medical diagnostics firm Ellume gets German backing for TB testing

Medical diagnostics firm Ellume gets German backing for TB testing

7 January 2019, Peter Williams This article originally appeared in The Australian, print and online, on 7th January 2019. View the original here on The Australian Website. Brisbane medical diagnostics company Ellume has received a $US15 million ($21m) investment from German biotech Qiagen as part of a broader strategic partnership between the two companies to detect tuberculosis. Clinical trials for a […]
Read More
Ellume spreads global wings with GSK deal

Ellume spreads global wings with GSK deal

11 December 2018, Sarah-Jane Tasker This article originally appeared in The Australian, print and online, on 11th December 2018. View the original here on The Australian Website. Brisbane medical diagnostics company Ellume has signed a significant deal with pharmaceutical giant GSK for digital consumer products, ahead of a potential market listing. Ellume founder and managing directory Sean Parsons said the […]
Read More
Page 3 of 3123
Recent Posts
  • Over-the-counter COVID-19 testing now available at CVS Pharmacy
  • Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test
  • U.S. strikes $230 million deal for over-the-counter Covid tests
  • A fast, at-home coronavirus test will be available to Americans this year
  • U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests
Archives
Categories
Business
Scroll

ellume logo white

ABN 13 141 767 660
57 Didsbury Street,
East Brisbane, Queensland 4169
Australia

MENU

Home
About Us
COVID-19 Response
Consumer Products
Professional Products
Global Public Health Solutions
Our Tech
News

CONTACT US

Corporate / General Enquiries:
+61 7 3393 1448
Sales / Product Enquiries:
+61 7 3393 1448 (outside the U.S.)
1-888-885-6121 (within U.S.)
Email Enquiries
Terms of Use
Privacy Policy
Whistleblower Policy

Some Ellume products are pending regulatory clearance – NOT AVAILABLE FOR SALE © Ellume Limited 2020